gemcitabine has been researched along with carbonates in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, H; He, Z; Kan, Q; Kou, L; Li, D; Li, Z; Luo, C; Na, K; Sun, J; Wang, K; Wang, M; Zhang, H; Zhao, D; Zhong, L | 1 |
| Babu, T; Gandin, V; Gibson, D; Ishan, M; Karmakar, S; Nemirovski, A; Yempala, T | 1 |
2 other study(ies) available for gemcitabine and carbonates
| Article | Year |
|---|---|
Striking a Balance between Carbonate/Carbamate Linkage Bond- and Reduction-Sensitive Disulfide Bond-Bearing Linker for Tailored Controlled Release: In Situ Covalent-Albumin-Binding Gemcitabine Prodrugs Promote Bioavailability and Tumor Accumulation.
Topics: Animals; Biological Availability; Carbamates; Carbonates; Cell Line, Tumor; Delayed-Action Preparations; Deoxycytidine; Disulfides; Endocytosis; Female; Gemcitabine; Humans; Intracellular Space; Mice; Oxidation-Reduction; Prodrugs; Rats; Serum Albumin, Bovine | 2018 |
Expanding the Arsenal of Pt
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbonates; Carcinoma, Lewis Lung; Cell Line, Tumor; Cisplatin; Deoxycytidine; Drug Screening Assays, Antitumor; Estramustine; Female; Gemcitabine; Humans; Ligands; Male; Mice, Inbred C57BL; Organoplatinum Compounds; Paclitaxel; Prodrugs; Prohibitins; Structure-Activity Relationship | 2019 |